IDEAYA Biosciences, Inc. Skyrocketed
IDEAYA Biosciences, Inc. (IDYA:NASDAQ) rocketted at $20.26, representing a gain of 35.7%. On Mon, Apr 24, 2023, IDYA:NASDAQ touched a New 2-Week High of $20.26. The stock appeared on our News Catalysts scanner on Mon, Apr 24, 2023 at 05:12 PM in the 'PUBLIC OFFERING' category. From Mon, Apr 10, 2023, the stock recorded 40.00% Up Days and 54.55% Green Days
About IDEAYA Biosciences, Inc. (IDYA:NASDAQ)
IDEAYA Biosciences Inc an oncology-focused medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.
Top 10 Gainers:
- IN8bio Inc. (INAB:NASDAQ), 183.02%
- Aclarion Inc. (ACON:NASDAQ), 74.62%
- Caravelle International Group (CACO:NASDAQ), 48.65%
- IDEAYA Biosciences, Inc. (IDYA:NASDAQ), 35.7%
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 33.33%
- Mangoceuticals Inc. (MGRX:NASDAQ), 31.76%
- Getty Images Holdings Inc. Class A (GETY:NYSE), 31.03%
- Sonendo Inc. (SONX:NYSE), 30.15%
- Fuel Tech, Inc. (FTEK:NASDAQ), 27.35%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 24.9%